Indaptus Therapeutics Inc. INDP
$3.50
▲ +0.28% 24H
About
Indaptus Therapeutics Inc. is a clinical-stage biotechnology company focused on developing systemically administered immunotherapies for cancer and chronic viral infections. The company’s core platform leverages proprietary, attenuated, killed, non-pathogenic Gram-negative bacteria engineered to reduce intravenous toxi…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees5
TickerINDP
Statistics
Market Cap$396.3M
Revenue (TTM)$0
Net Income-$20.8M
Net Margin—
EPS$-21.58
P/E-0.15
P/S—
P/B324.55
EV/EBITDA-20.31
ROE-931.8%
Dividend Yield—
Price$3.50
Data: Twelve Data · Revenue = mcap / P/S